Preview of Forestar Group’s first quarter 2025 results



Preview of Forestar Group’s first quarter 2025 results



Source link

  • Related Posts

    Lilly weight-loss pill orforglipron could get FDA approval by 2026, CEO Dave Ricks says

    Eli Lilly & Co., the Fortune 500 pharma firm that makes weight-loss injection Zepbound (tirzepatide), has a comparable oral drug in the works that could be approved by the FDA…

    US crude falls the most in two months as Trump’s output and tariff plans create uncertainty

    Jan. 21, 2025 7:50 PM ETUnited States Oil Fund, LP ETF (USO), CL1: HOWUCO, BOD, USL, SCO, BNO, GUSH, DROP, USE, CO1:COMFor: Carl Surran, SA News Editor SlavkoSereda/iStock via Getty…

    Leave a Reply

    Your email address will not be published. Required fields are marked *